World's Best Scientists 2026 revealed!
Masayuki Miyasaka

Masayuki Miyasaka

D-Index & Metrics

Immunology

D-Index
101
Citations
30444
World Ranking
710
National Ranking
23

Medicine

D-Index
100
Citations
30234
World Ranking
8363
National Ranking
217

Masayuki Miyasaka publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Masayuki Miyasaka sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 469 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Masayuki Miyasaka D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Masayuki Miyasaka sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Masayuki Miyasaka is a researcher affiliated with Osaka University in Japan. Their work spans several fields, primarily focusing on medicine, immunology and microbiology, as well as biochemistry, genetics, and molecular biology.

Their research covers a range of topics including lymphatic system and diseases, immune responses and vaccinations, COVID-19 clinical research studies, phagocytosis and immune regulation, immune cells in cancer, adenosine and purinergic signaling, and mechanical circulatory support devices.

The scientist's recent publications include:

  • Is BCG vaccination causally related to reduced COVID-19 mortality? (2020, EMBO Molecular Medicine)
  • Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance (2020, Journal of Clinical Investigation)
  • CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels (2022, Cancer Science)
  • Infection with the enteric pathogen C. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node (2022, Mucosal Immunology)
  • Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages (2021, Proceedings of the National Academy of Sciences)

Frequent co-authors in Miyasaka's work include Haruko Hayasaka, Daichi Kobayashi, Vanessa Gauttier, Sabrina Pengam, and Caroline Mary.

Miyasaka's research has been published in prominent venues such as Frontiers in Immunology, Inflammation and Regeneration, EMBO Molecular Medicine, Journal of Clinical Investigation, and Cancer Science.

Best Publications

  • Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.

    Masanori Hatakeyama;Mitsuru Tsudo;Seijiro Minamoto;Takeshi Kono

  • Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5

    Satoshi Uematsu;Kosuke Fujimoto;Myoung Ho Jang;Bo Gie Yang

  • Lymphocyte trafficking across high endothelial venules: dogmas and enigmas

    Masayuki Miyasaka;Toshiyuki Tanaka

  • Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells.

    Satoshi Uematsu;Myoung Ho Jang;Nicolas Chevrier;Zijin Guo

  • CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes.

    Myoung Ho Jang;Nagako Sougawa;Toshiyuki Tanaka;Takako Hirata

  • Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat

    R. L. Zhang;Michael Chopp;Michael Chopp;Y. Li;C. Zaloga

  • Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

    I Kurose;D C Anderson;M Miyasaka;T Tamatani

  • Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage.

    I Kurose;P Kubes;R Wolf;D C Anderson

  • Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver.

    Anwar Farhood;G. M. Mcguire;A. M. Manning;M. Miyasaka

  • Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat

    Yoshiyuki Matsuo;Hiroshi Onodera;Yusei Shiga;Hidetaka Shozuhara

  • ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan.

    Kouji Kuno;Yasunori Okada;Hiroto Kawashima;Hiroyuki Nakamura

  • Regional differences in constitutive and induced ICAM-1 expression in vivo

    J. Panes;M. A. Perry;D. C. Anderson;A. Manning

  • Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle.

    H. Sorimachi;N. Toyama-Sorimachi;T. C. Saido;H. Kawasaki

  • Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.

    Mitsuru Tsudo;Fujiko Kitamura;Masayuki Miyasaka

  • Requirement and role of C5a in acute lung inflammatory injury in rats.

    Michael S. Mulligan;Elisabeth Schmid;Elisabeth Schmid;Beatrice Beck-Schimmer;Beatrice Beck-Schimmer;Gerd O. Till

  • Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome

    Kazuo Chin;Takaya Nakamura;Kouichi Shimizu;Michiaki Mishima

  • Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies.

    Takuya Tamatani;Masaharu Kotani;Masayuki Miyasaka

  • Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1

    Michael S. Mulligan;Ara A. Vaporciyan;Masayuki Miyasaka;Takuya Tamatani

  • Chemokines in tumor progression and metastasis

    Toshiyuki Tanaka;Zhongbin Bai;Yuttana Srinoulprasert;BoGi Yang

  • A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation.

    Noriko Toyama-Sorimachi;Hiroyuki Sorimachi;Yoshimi Tobita;Fujiko Kitamura

  • Shear stress inhibits adhesion of cultured mouse endothelial cells to lymphocytes by downregulating VCAM-1 expression

    J Ando;H Tsuboi;R Korenaga;Y Takada

Frequent Co-Authors

Toshiyuki Tanaka
Toshiyuki Tanaka Hyogo University of Health Sciences
Takuya Tamatani
Takuya Tamatani Japan Tobacco (United States)
Peter A. Ward
Peter A. Ward University of Michigan–Ann Arbor
Ko Okumura
Ko Okumura Juntendo University
Hideo Yagita
Hideo Yagita Juntendo University
Morito Monden
Morito Monden Osaka University
Makoto Suematsu
Makoto Suematsu Keio University
Sirpa Jalkanen
Sirpa Jalkanen University of Turku
Junken Aoki
Junken Aoki Tohoku University
Tadatsugu Taniguchi
Tadatsugu Taniguchi University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways. Many professionals begin with nursing-focused programs to gain foundational knowledge before specializing further. For example, transitioning from a Family Nurse Practitioner to a specialized role often involves completing an fnp to acute care np bridge program. This offers focused training on complex patient care in acute settings.

Students seeking faster entry into nursing roles may explore accelerated np programs online. These programs offer flexible pacing and remote learning, making it easier to balance studies with personal commitments. Similarly, non-nurses looking to enter the field can benefit from online absn programs for non nurses, which provide intensive, accessible pathways to earn a Bachelor of Science in Nursing.

When selecting programs, it’s important to consider acceptance rates to improve admission chances. Exploring absn programs with high acceptance rates can help prospective students identify schools with more flexible entry requirements, smoothing the transition into healthcare careers that complement immunology studies.

Best Scientists Citing Masayuki Miyasaka

Trending Scientists

Recently Published Articles